Lack of cross-reaction between antibodies to β2-glycoprotein-I and oxidized low-density lipoprotein in patients with antiphospholipid syndrome

British Journal of Rheumatology

Volumn 37, Issue 7, 1998, Pages 746-749

  Tinahones, F J ^a,d   Cuadrado, M J ^b   Khamashta, M A ^c   Mujic, F ^c   Gomez Zumaquero, J M ^a   Collantes, E ^b   Hughes, G R V ^c  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^b HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^c ST THOMAS HOSPITAL   (United Kingdom)

^d NONE   (Spain)

Author keywords

2 glycoprolein I; Antiphospholipid syndrome; Inhibition techniques; Oxidized LDL

Indexed keywords

AUTOANTIBODY; BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; OXIDIZED LOW DENSITY LIPOPROTEIN; PHOSPHOLIPID ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AGED; ANTIPHOSPHOLIPID SYNDROME; APOLIPOPROTEINS; AUTOANTIBODIES; BETA 2-GLYCOPROTEIN I; CROSS REACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLYCOPROTEINS; HUMANS; IMMUNOGLOBULIN G; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; OXIDATION-REDUCTION;

EID: 0031821374     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Palinski W, Rosenfeld ME, Ylä-Herttuala S, Gurther GC, Socher SA, Butler S et al. Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci USA 1989;86:1372-6.
2. Salonen JT, Ylä-Herttuala S, Yamamoto R, Butler S, Korpela H, Salonen K, et al. Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet 1992;339:883-7.
3. McNeil HP, Chesterman CN, Krilis SA. Immunology and clinical importance of antiphospholipid antibodies. Adv Immunol 1991;49:193-280.
4. Harris EN, Hughes GRV, Gharavi AE. Antiphospholipid antibodies: an elderly statesman dons new garments. J Rheumatol 1987;14(suppl. 13):208-13.
5. Galli M, Comfurius P, Maassen C, Hemker HC, De Baets MH, Van Breda-Vriesman PJ et al. Anticardiolipin antibodies directed not to cardiolipin but a plasma protein factor. Lancet 1990;335:1544-7.
6. McNeil HP, Simpson RJ, Chesterman CN, Krilis SA. Antiphospholipid antibodies directed against a complex antigen that includes a lipid binding inhibitor of coagulation β2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 1990;87:4120-4.
7. Matsuura E, Igarashi V, Yasuda T, Triplett DA, Koike T. Anticardiolipin antibodies recognise beta(2)-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J Exp Med 1994;179:457-62.
8. Viard JP, Amoura Z, Bach JF. Association of antiβ2-glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus. Am J Med 1992;93:181-6.
9. Amengual O, Atsumi T, Khamashta MA, Tinahones F, Cuadrado MJ, Hughes GRV. Antibodies against oxidised low-density lipoprotein (ox-LDL) in 107 patients with antiphospholipid syndrome (APS). Arthritis Rheum 1996;39:S96 (Abstract).
10. Vaarala O, Alfthan G, Jauhiainen M, Leirisalo-Repo M, Aho K, Palosuo T. Crossreaction between antibodies to oxidised low-density lipoprotein and to cardiolipin in systemic lupus erythematosus. Lancet 1993;341:923-5.
11. Matsuura E, Katahira T, Igarashi Y, Koike T. β2-glycoprotein I bound to oxidatively modified lipoproteins could be targeted by anticardiolipin antibodies. Lupus 1994;3:314 (Abstract).
12. Harris EN, Baguley E, Asherson RA, Hughes GRV. Clinical and serological features of the antiphospholipid syndrome (APS). Br J Rheumatol 1987;26(suppl. 2):19 (Abstract).
13. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
14. Harris EN, Gharavi AE, Patel SP, Hughes GRV. Evaluation of the anticardiolipin antibody test: report of an international workshop held 4th April 1986. Clin Exp Immunol 1987;68:215-22.
15. Vaarala O. Antiphospholipid antibodies and atherosclerosis. Lupus 1996;5:442-7.
16. Vaarala O, Puurunen M, Lukka M, Alfthan G, Leirisalo-Repo M, Aho K et al. Affinity-purified cardiolipin-binding antibodies show heterogeneity in their binding to oxidized low-density lipoprotein. Clin Exp Immunol 1996;104:269-74.
17. Ghavari AE, Harris EN, Sammaritano LR et al. Do patients with antiphospholipid syndrome have antibodies to and β2 glycoprotein I? J Lab Clin Med 1993; 122:426-31.